Withdrawn valsartan meds not linked to short-term cancer risk

Expedited analysis of NDMA-contaminated products finds no markedly raised short-term cancer risk Related items fromOnMedica GPs defend practice on prescribing statins Too few women take part in many CVD clinical trials MHRA tightens licence restrictions on valproate for women Cancer patients using complementary meds die sooner Drugs regulators “put profits before patients”
Source: OnMedica Latest News - Category: UK Health Source Type: news